The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.
Source: [MarketWatch](https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c?mod=mw_rss_topstories)
Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
Updates from the opening day’s card at York Constitution River can fill Bow Echo void | Mail Greg It all went according to plan for the low-numbered stalls there, as Lexington Blitz fired out into the lead and gave the far side an advantage that they never surrendered. The first four home were d...
3 points, 1 comments on Hacker News
3 points, 1 comments on Hacker News
Developing story — details emerging. Check the source link for the latest updates.
Although increased cell proliferation is a hallmark of cancerous tissues, in some cases it may actually protect against tumor growth, according to a new study by Caltech researchers. Using mathematical models, the work suggests a new paradigm for the earliest stages of cancer development.